Name: Hospital Acquired Infection Control Market, By Product and Service (Consumables, Equipment, and Services), By End User (Hospitals and ICUs, Ambulatory Surgical Centers, and Long-term Care Facilities), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Brand: Coherent Market Insights
SKU: CMR-6b69c810cf
Price: 4500 USD
Availability: InStock

報告摘要

The global hospital acquired infection control market is estimated to be valued at USD 8.12 Bn in 2026 and is expected to reach USD 13.46 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033. Hospital-acquired infections (HAIs), also called nosocomial infections, is defined as any infection acquired by a patient during medical treatment in a health-care setting. Types include central line-associated bloodstream infections (CLABSI), catheter-associated urinary tract infections (CAUTI), surgical site infections (SSI) and ventilator-associated pneumonia (VAP). Hospital-acquired infections still present major challenges, leading to higher patient morbidity and mortality, length of stay, and costs. The global hospital acquired infection control market is segmented by the type of product and solution such as disinfectants, sterilization devices, infection surveillance software, and antimicrobial coating and personal protective clothing. The demand for hospital-acquired infection control market has increased because of growing prevalence of hospital acquired infections, increasing surgical operations, extending healthcare infrastructure, mounting problem of antimicrobial resistance and strict healthcare infection prevention guidelines globally. Market Dynamics The global hospital acquired infection control market is driven by increasing prevalence of hospital-acquired infections, the growing number of surgical procedures, and the rising number of elderly and immunocompromised patients. Increasing emphasis on rigorous infection prevention practices and guideline issued by organizations like WHO, CDC and ECDC, the rising threat of multidrug-resistant organisms (MDROs) and increasing demand for improved sterilization and disinfection products are other contributing factors. However, a number of constraints are present in the market, such as increasing adoption of advanced and high-cost technologies, restricted healthcare budgets in underdeveloped countries, and improper implementation of infection prevention practices in the past. Nevertheless, advancements such as AI-enabled infection surveillance solutions, UV-C disinfection, robotic sterilization technologies, antimicrobial coatings, and considerable healthcare infrastructure investment along with expanding awareness of the significance of infection prevention in developing economies will offer new opportunities for growth in hospital acquired infection control market. Key Features of the Study • This report provides in-depth analysis of the global hospital acquired infection control market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global hospital acquired infection control market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include STERIS plc, Getinge AB, Becton, Dickinson and Company, Ecolab Inc., 3M Company, Advanced Sterilization Products (ASP), bioMérieux SA, Belimed AG, Sotera Health Company, and Olympus Corporation • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global hospital acquired infection control market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hospital acquired infection control market Market Segmentation • Services Insights (Revenue, USD Bn, 2021 - 2033) o Recruitment Services o Managed Services o Homecare Services o Specialist Care Services • Industry Verticals Insights (Revenue, USD Bn, 2021 - 2033) o Pharmaceutical and Biotechnology o Medical Devices o Nursing/Healthcare o Others • Regional Insights (Revenue, USD Bn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o STERIS plc o Getinge AB o Becton, Dickinson and Company o Ecolab Inc. o 3M Company o Advanced Sterilization Products (ASP) o bioMérieux SA o Belimed AG o Sotera Health Company o Olympus Corporation

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Hospital Acquired Infection Control Market, By Product and Service  Global Hospital Acquired Infection Control Market, By End User  Global Hospital Acquired Infection Control Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Industry Trends 4. Global Hospital Acquired Infection Control Market, By Product and Service, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Consumables  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Equipment  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Services  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Global Hospital Acquired Infection Control Market, By End User, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Hospitals and ICUs  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Ambulatory Surgical Centers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Long-term Care Facilities  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Hospital Acquired Infection Control Market, By Region, 2021 - 2033, Value (USD Bn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn) o South Africa o North Africa o Central Africa 7. Competitive Landscape o STERIS plc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Getinge AB  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Becton, Dickinson and Company  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Ecolab Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o 3M Company  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Advanced Sterilization Products (ASP)  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o bioMérieux SA  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Belimed AG  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Sotera Health Company  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Olympus Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 8. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 9. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on ‘Hospital Acquired Infection Control Market' - Global forecast to 2033

圖表清單 List of Tables & Figures

NA NA

提及公司

o STERIS plco Getinge ABo BectonDickinson and Companyo Ecolab Inc.o 3M Companyo Advanced Sterilization Products (ASP)o bioMérieux SAo Belimed AGo Sotera Health Companyo Olympus Corporation

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們

Single User Price	$4,500 USD
Site License Price	$7,000 USD
Enterprisewide Price (Global Site License)	$10,000 USD

Hospital Acquired Infection Control Market, By Product and Service (Consumables, Equipment, and Services), By End User (Hospitals and ICUs, Ambulatory Surgical Centers, and Long-term Care Facilities), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

授權報價

報告摘要

提及公司